These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 11973635
1. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. Xia DJ, Zhang WP, Zheng S, Wang J, Pan JP, Wang Q, Zhang LH, Hamada H, Cao X. Gene Ther; 2002 May; 9(9):592-601. PubMed ID: 11973635 [Abstract] [Full Text] [Related]
2. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. J Immunol; 1998 Dec 01; 161(11):6238-44. PubMed ID: 9834111 [Abstract] [Full Text] [Related]
3. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W, He L, Cao X. Zhonghua Yi Xue Za Zhi; 1999 Mar 01; 79(3):170-3. PubMed ID: 11601032 [Abstract] [Full Text] [Related]
4. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Zhang W, He L, Yuan Z, Xie Z, Wang J, Hamada H, Cao X. Hum Gene Ther; 1999 May 01; 10(7):1151-61. PubMed ID: 10340547 [Abstract] [Full Text] [Related]
5. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen. Xia D, Zheng S, Zhang W, He L, Wang Q, Pan J, Zhang L, Wang J, Cao X. J Mol Med (Berl); 2003 Sep 01; 81(9):585-96. PubMed ID: 12937899 [Abstract] [Full Text] [Related]
6. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer. Wang Q, Yu H, Zhang L, Ju D, Pan J, Xia D, Yao H, Zhang W, Wang J, Cao X. J Mol Med (Berl); 2002 Sep 01; 80(9):585-94. PubMed ID: 12226740 [Abstract] [Full Text] [Related]
16. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X. Gene Ther; 2000 Oct 01; 7(19):1672-9. PubMed ID: 11083476 [Abstract] [Full Text] [Related]
17. Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells. Wargo JA, Schumacher LY, Comin-Anduix B, Dissette VB, Glaspy JA, McBride WH, Butterfield LH, Economou JS, Ribas A. Cancer Gene Ther; 2005 Jun 01; 12(6):516-27. PubMed ID: 15775996 [Abstract] [Full Text] [Related]
19. Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma. Ju DW, Tao Q, Cheng DS, Zhang W, Zhang M, Hamada H, Cao X. Gene Ther; 2000 Feb 01; 7(4):329-38. PubMed ID: 10694814 [Abstract] [Full Text] [Related]
20. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Yang S, Darrow TL, Vervaert CE, Seigler HF. Cell Immunol; 1997 Jul 10; 179(1):84-95. PubMed ID: 9259775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]